Genscript Biotech Corporation (GNNSF)
OTCMKTS · Delayed Price · Currency is USD
2.190
-0.010 (-0.45%)
Sep 4, 2025, 8:00 PM EDT

Genscript Biotech Statistics

Total Valuation

GNNSF has a market cap or net worth of 5.07 billion. The enterprise value is 4.68 billion.

Market Cap5.07B
Enterprise Value 4.68B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date Nov 14, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 2.18B
Shares Outstanding n/a
Shares Change (YoY) +4.08%
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.38B

Valuation Ratios

The trailing PE ratio is 1.63 and the forward PE ratio is 47.38.

PE Ratio 1.63
Forward PE 47.38
PS Ratio 6.12
PB Ratio 1.15
P/TBV Ratio 1.15
P/FCF Ratio 10,159.97
P/OCF Ratio 22.20
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 159.19, with an EV/FCF ratio of 9,383.80.

EV / Earnings 1.50
EV / Sales 5.61
EV / EBITDA 159.19
EV / EBIT n/a
EV / FCF 9,383.80

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.12.

Current Ratio 1.96
Quick Ratio 1.78
Debt / Equity 0.12
Debt / EBITDA 2.11
Debt / FCF 1,099.24
Interest Coverage 12.85

Financial Efficiency

Return on equity (ROE) is -1.94% and return on invested capital (ROIC) is 2.88%.

Return on Equity (ROE) -1.94%
Return on Assets (ROA) 2.56%
Return on Invested Capital (ROIC) 2.88%
Return on Capital Employed (ROCE) 3.71%
Revenue Per Employee 143,543
Profits Per Employee 539,353
Employee Count5,568
Asset Turnover 0.19
Inventory Turnover 8.23

Taxes

In the past 12 months, GNNSF has paid 17.59 million in taxes.

Income Tax 17.59M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +43.89% in the last 52 weeks. The beta is 0.96, so GNNSF's price volatility has been similar to the market average.

Beta (5Y) 0.96
52-Week Price Change +43.89%
50-Day Moving Average 2.12
200-Day Moving Average 1.64
Relative Strength Index (RSI) 60.49
Average Volume (20 Days) 20

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, GNNSF had revenue of 828.10 million and earned 3.11 billion in profits. Earnings per share was 1.41.

Revenue828.10M
Gross Profit 459.25M
Operating Income 179.43M
Pretax Income -42.99M
Net Income 3.11B
EBITDA 243.63M
EBIT 179.43M
Earnings Per Share (EPS) 1.41
Full Income Statement

Balance Sheet

The company has 938.36 million in cash and 548.52 million in debt, giving a net cash position of 389.84 million.

Cash & Cash Equivalents 938.36M
Total Debt 548.52M
Net Cash 389.84M
Net Cash Per Share n/a
Equity (Book Value) 4.42B
Book Value Per Share 2.03
Working Capital 576.28M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 228.41 million and capital expenditures -227.91 million, giving a free cash flow of 499,000.

Operating Cash Flow 228.41M
Capital Expenditures -227.91M
Free Cash Flow 499,000
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 55.46%, with operating and profit margins of 21.67% and 375.74%.

Gross Margin 55.46%
Operating Margin 21.67%
Pretax Margin -5.19%
Profit Margin 375.74%
EBITDA Margin 29.42%
EBIT Margin 21.67%
FCF Margin 0.06%

Dividends & Yields

GNNSF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.08%
Shareholder Yield n/a
Earnings Yield 61.37%
FCF Yield 0.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5